quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:15·38d
INSIDERFiling
Phibro Animal Health Corporation logo

President and CEO Bendheim Jack converted options into 100,000 shares and sold $258,245 worth of shares (5,280 units at $48.91) (SEC Form 4)

PAHC· Phibro Animal Health Corporation
Health Care
Original source

Companies

  • PAHC
    Phibro Animal Health Corporation
    Health Care

Recent analyst ratings

  • Apr 15UpdateCitigroup$62.00
  • Jul 7UpdateAnalyst$35.00
  • Jun 16UpdateBNP Paribas Exane$24.00
  • Sep 10UpdateJP Morgan$22.00
  • Dec 7UpdateExane BNP Paribas$9.00
  • Dec 21UpdateROTH Capital$18.00

Related

  • INSIDER8h
    President and CEO Bendheim Jack sold $1,157,091 worth of shares (21,120 units at $54.79) as part of a pre-agreed trading plan (SEC Form 4)
  • INSIDER7d
    SEC Form 4 filed by Bendheim Jack
  • ANALYST8d
    Citigroup initiated coverage on Phibro Animal Health with a new price target
  • SEC9d
    Phibro Animal Health Corporation filed SEC Form 8-K: Leadership Update
  • SEC16d
    SEC Form SCHEDULE 13G filed by Phibro Animal Health Corporation
  • INSIDER23d
    SEC Form 4 filed by Bendheim Jack
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Phibro Animal Health Corporation
  • INSIDER28d
    SEC Form 4 filed by Bendheim Jack
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022